Ankle Oedema and Sympathetic Activation
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 65 (Suppl 2) , 21???27-27
- https://doi.org/10.2165/00003495-200565002-00004
Abstract
Ankle oedema is a common adverse event during treatment with dihydropyridine (DHP) calcium channel antagonist therapy, the incidence of which is dose related. The three mechanisms put forward to...Keywords
This publication has 14 references indexed in Scilit:
- Heterogeneous effect of calcium antagonists on leg oedemaJournal Of Hypertension, 2003
- Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipineJournal Of Hypertension, 2003
- Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertensionJournal Of Hypertension, 2000
- Sexual function in hypertensive males treated with lisinopril or atenololA cross-over studyAmerican Journal of Hypertension, 1998
- Oedema formation with the vasodilators nifedipine and diazoxide: direct local effect or sodium retention?1996
- Oedema formation with the vasodilators nifedipine and diazoxideJournal Of Hypertension, 1996
- Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group.1996
- Microvascular actions of calcium channel antagonistsEuropean Journal of Pharmacology, 1991
- Microvascular effects and oedema formation of felodipine in man.1989
- Microvascular Mechanisms Involved in Calcium Antagonist Edema FormationJournal of Cardiovascular Pharmacology, 1987